-
Molecular Characterization of NRG-HN003: Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
Study
phs004486
-
Blood and Marrow Transplant Clinical Trials Network - A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN-1703-BioLINCC)
Study
phs004711
-
Blood and Marrow Clinical Trials Network - A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy Versus Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (BMT CTN-0102-BioLINCC)
Study
phs004672
-
PIGR+RORC+ Dendritic Cells (PRDCs) are an Immunomodulatory Subset Enriched in Malignant Ascites
Study
phs004309
-
SWOG S1512: A Phase II Study of PD-1 Blockade with Pembrolizumab In Patients with Locally Advanced and Metastatic Desmoplastic Melanoma
Study
phs004123
-
scRNA-seq of Multiple Myeloma and Tumor Microenvironment Cells from Bone Marrow During CAR T-Cell Therapy
Study
phs004878
-
Cetuximab and Nivolumab in Recurrent/Metastatic Head and Neck Cancer
Study
phs004268
-
Molecular Profiling of Head and Neck Squamous Cell Carcinomas
Study
phs004476
-
Cutaneous Squamous Cell Carcinoma: Integrating Germline and Somatic Alterations that Underlie Tumor Progression
Study
phs003681
-
Molecular Characterization of the Immunological Landscape in Human Brain Tumors
Study
phs004853
-
Kids First: Genomic Analysis of Pediatric Rhabdomyosarcoma
Study
phs004306
-
Blood and Marrow Clinical Trials Network - Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (BMT CTN-1302-BioLINCC)
Study
phs004705
-
Longitudinal Analysis of Multiple Myeloma: Bone Marrow Recovery and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity
Study
phs004383
-
scRNAseq Analysis of Osteosarcoma Reveals Conserved and Distinct Ecosystems Across Sites and Species
Study
phs004431
-
Therapeutic Hypothermia After Pediatric Cardiac Arrest (In-Hospital) (THAPCA-IH-BioLINCC)
Study
phs004645
-
NCTN: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study (S0931)
Study
phs004249
-
Targeting SS18-SSX Biology in Synovial Sarcomagenesis
Study
phs004771
-
NCTN: A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation (A071102)
Study
phs004615
-
Childhood Cancer Data Initiative (CCDI): Metastatic Osteosarcoma Spatial Profiling
Study
phs003975
-
NCTN: Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients with Melanoma That Has Been Removed by Surgery (E4697)
Study
phs004396
-
Dendritic Cell Redundancy Enables Priming of Anti-Tumor CD4 T Cells in Pancreatic Cancer
Study
phs004508
-
Biopsy Analysis of Trial S1616: Ipilimumab Plus Nivolumab versus Ipilimumab Alone in Patients with Anti-PD-1-Refractory Melanoma
Study
phs004054
-
Define the Role of Chromosome 17q Gain in Neuroblastoma Malignancy
Study
phs004436
-
SMARCA4 Loss in STK11/KEAP1 Co-Mutant Lung Adenocarcinoma
Study
phs004424
-
Proteogenomic Studies to Understand Mechanisms and Drivers of Resistance to Immunotherapies
Study
phs004511
-
Transcriptome of Human Merkel Cell Carcinoma
Study
phs003411
-
Single-Cell eQTL and isoQTL Profiling of Normal Lung Tissues from Never-Smoking Korean Women
Study
phs004420
-
NCTN: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma (E2805)
Study
phs004235
-
Patient-Derived Xenografts in Multiple Myeloma
Study
phs004479
-
Transcriptomic Profiling of Lung Adenocarcinoma From Never-Smokers
Study
phs003955
-
Transcriptomic Profiling of CD8+ T Cells during Mosunetuzumab Therapy
Study
phs004893
-
NCTN: Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment (AHEP0731)
Study
phs004135
-
NCTN: Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus Radiation Therapy for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast (RTOG-98-04)
Study
phs004264
-
Real-Time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Study
phs001652
-
Proteogenomic Characterization of Human Uterine Cervical Cancer
Study
phs002916
-
Single Cell RNA Sequencing of Metastatic Adrenocortical Carcinoma and Tumor-Free Tissue
Study
phs003987
-
Childhood Cancer Data Initiative (CCDI): Metastatic Osteosarcoma snMultiome Profiling
Study
phs004490
-
NCTN: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma (RTOG-1010)
Study
phs004237
-
Multicenter Hemophilia Cohort Studies (MHCS-BioLINCC)
Study
phs004485
-
Genome Sequencing of Individuals with PTEN Hamartoma Tumor Syndrome
Study
phs004787
-
Retrovirus Epidemiology Donor Study-II (REDS II) Natural History of Disease and Laboratory Findings in Trypanosoma Cruzi Antibody-Positive Brazilian Blood Donors (CHAGAS) (REDS_II_CHAGAS_BioLINCC)
Study
phs004528
-
National Cancer Institute - Population Structure and Natural Selection in the Epidemiology of Burkitt Lymphoma in East African Children and Minors (EMBLEM) study in Uganda
Study
phs001705
-
Childhood Cancer Survivor Study (CCSS)
Study
phs001327
-
CPTAC Proteogenomic Study
Study
phs001287
-
Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case-Control Consortium (PanScan)
Study
phs000206
-
Multivalent State Transitions Shape the Intratumoral Composition of Small Cell Lung Carcinoma
Study
phs003102
-
Genomic Predictors of Response to Immune Checkpoint Therapy
Study
phs001493
-
Childhood Cancer Data Initiative (CCDI): Clonal Evolution During Metastatic Spread in High-Risk Neuroblastoma
Study
phs003111
-
Molecular Correlatives from SU2C-SARC032
Study
phs003921
-
Multi-Omic Investigation of Beckwith-Wiedemann Syndrome Hepatoblastoma
Study
phs002614
-
Single-Cell Transcriptomic Analysis of Kaposi Sarcoma
Study
phs003800
-
Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome
Study
phs002723
-
Gabriella Miller Kids First (GMKF) Pediatric Research Program in Susceptibility to Ewing Sarcoma Based on Germline Risk and Familial History of Cancer
Study
phs001228
-
Cellular and Molecular Characterization of Renal Cell Carcinoma
Study
phs002252
-
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick)
Study
phs003099
-
Genomic Sequencing of Pediatric Rhabdomyosarcoma
Study
phs000720
-
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Study
phs003438
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
Natural Killer Cell and Lymphocyte-Targeted Immunotherapies in Cancer
Study
phs002681
-
Genetic analysis of paired diagnosis and relapse neuroblastomas
Study
EGAS50000002000
-
Whole Genome Sequencing of cell-free-DNA in High-Risk Smoldering Multiple Myeloma
Study
EGAS50000001657
-
Multi-omics datasets (WES, RNA-seq) of mesothelioma MIST3 study, a phase IIA AXL/PD1 inhibition clinical trial
Study
EGAS50000001704
-
IMMUcan CRC1 cohort
Study
EGAS50000002159
-
IMMUcan CRCKUL CRC1 cohort
Study
EGAS50000002164
-
IMMUcan CRCCLB CRC1 cohort
Study
EGAS50000002170
-
IMMUcan CRCStLuc CRC1 cohort
Study
EGAS50000002185
-
Raw sequencing data from a phase 2 trial of dasatinib in patients with relapsed/refractory nodal T-follicular helper cell lymphoma
Study
EGAS50000002081
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
scRNA-seq Glioblastoma–PBMC Co-culture Dataset
Dataset
EGAD50000001617
-
Single cell atlas of follicular lymphoma
Study
EGAS50000002080
-
Potency-Guided Tumor-Infiltrating Lymphocyte Therapy in Metastatic Uveal Melanoma: A Phase 2 Trial
Study
phs004955
-
Intron Retention Regulates STAT2 Function and Predicts Response to Immunotherapy in Lung Adenocarcinoma
Study
phs004211
-
A Phase III Randomized Double-Blinded Study Comparing the Combination of the BRAF Inhibitor Dabrafenib and the MEK Inhibitor Trametinib to Dabrafenib and Placebo as First-Line Therapy in Subjects with Unresectable (Stage IIIC) or Metastatic (Stage IV) Melanoma
Study
phs004958
-
NCTN_NCORP: A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children (ACCL0431)
Study
phs004156
-
Multi-Platform Analysis of Matched Well- and Dedifferentiated Tumors Identify Novel Drivers of Liposarcomagenesis
Study
phs004774
-
Genome and transcriptome sequence data from a rhabdomyosarcoma, alveolar tumor patient
Dataset
EGAD00001015335
-
Genome and transcriptome sequence data from a high-grade glioma, glioblastoma tumor patient
Dataset
EGAD00001015336
-
Genome and transcriptome sequence data from a neuroblastoma tumor patient
Dataset
EGAD00001015337
-
Genome and transcriptome sequence data from a osteosarcoma tumor patient
Dataset
EGAD00001015338
-
RNAseq Atlas in HCC tumors
Dataset
EGAD00001015341
-
Exome Atlas in HCC tumors
Dataset
EGAD00001015342
-
FASTQ file for paper titled "Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression"
Dataset
EGAD00001015356
-
Genomic and transcriptomic landscape of T-cell lymphoblastic lymphoma compared to T-cell acute lymphoblastic leukemia: similar subtypes and different fusions
Dataset
EGAD00001015357
-
Activation of Wnt/β-catenin signalling by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary gland basal cell adenoma - WES
Dataset
EGAD00001015365
-
Activation of Wnt/β-catenin signalling by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary gland basal cell adenoma - RNA
Dataset
EGAD00001015366
-
Dataset for manuscript titled: Spatial Intra-Tumour Heterogeneity and Treatment-Induced Genomic Evolution in Oesophageal Adenocarcinoma: Implications for Prognosis and Therapy
Dataset
EGAD00001015373
-
Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 90 cases
Dataset
EGAD00001015376
-
Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 90 cases
Dataset
EGAD00001015377
-
Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 90 cases
Dataset
EGAD00001015378
-
Exploring the driver events of eccrine poromas and porocarcinomas: A retrospective, cross-institutional study of 90 cases
Dataset
EGAD00001015379
-
Genome and transcriptome sequence data from a diffuse intrinsic pontine glioma tumor patient
Dataset
EGAD00001015284
-
Genome and transcriptome sequence data from a ewing sarcoma tumor patient
Dataset
EGAD00001015286
-
Genome and transcriptome sequence data from a ependymoma tumor patient
Dataset
EGAD00001015287
-
Genome and transcriptome sequence data from a glioblastoma tumor patient
Dataset
EGAD00001015288
-
Genome and transcriptome sequence data from a NUT midline carcinoma tumor patient
Dataset
EGAD00001015289
-
Genome and transcriptome sequence data from a angiosarcoma tumor patient
Dataset
EGAD00001015290
-
Genome and transcriptome sequence data from a gliomatosis cerebri anaplastic astrocytoma tumor patient
Dataset
EGAD00001015292
-
Genome and transcriptome sequence data from a osteosarcoma tumor patient
Dataset
EGAD00001015293
-
Genome and transcriptome sequence data from a neuroblastoma tumor patient
Dataset
EGAD00001015294
-
Genome and transcriptome sequence data from a metastatic alveolar rhabdomyosarcoma tumor patient
Dataset
EGAD00001015295